Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers

BackgroundFibrotic focus (FF) has been observed in breast cancers and is suggested to be an important prognostic marker. However, most of these observations were reported by the same group of investigators with similar sample cohort. The relationship of FF and molecular subtypes as well as its associated prognosis has not been elucidated.MethodsIn this study, 450 cases of breast carcinomas were evaluated for the presence of FF and its association with clinicopathologic parameters and biomarkers.ResultsFF was found in 18.7 % of all consecutive cases. FF was associated positively with infiltrative margins (p = 0.03) but negatively with extensive in situ component (p < 0.001) and lymphocytic infiltration (p < 0.001). It was positively associated with estrogen receptor (p = 0.007) but negatively with human epidermal growth factor receptor 2 (HER2; p = 0.001), epidermal growth factor receptor (p = 0.021), Ki-67 (p = 0.001), and c-kit (p = 0.009). Concomitantly, FF was seen more commonly in luminal A cancers (p < 0.001) but less so in luminal B (p = 0.045) and HER2-overexpressing cancers (p = 0.011). Analysis on patient outcome (median 41 months, range 1–69 months) indicated that FF was an independent poor prognostic factor for disease-free survival (hazard ratio = 2.57; 95 % confidence interval = 1.267–5.214, p = 0.009), particularly in the luminal B subtype.ConclusionsThe findings suggested that FF is associated with specific tumor morphology of an infiltrative, stellate pattern (typical invasive ductal carcinoma-not otherwise specified) rather than round, cellular mass with intense lymphocytic infiltrate (basal-like breast cancers). The poor prognostic implication of FF is additional and independent of other adverse prognostic indicators.

[1]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  S. Hirohashi,et al.  Fibrotic focus in infiltrating ductal carcinoma of the breast: A significant histopathological prognostic parameter for predicting the long-term survival of the patients , 1998, Breast Cancer Research and Treatment.

[3]  Ian O Ellis,et al.  Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis , 2005, Modern Pathology.

[4]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.

[5]  S. Paik,et al.  Pathologic findings from the national surgical adjuvant breast project (protocol 6) I. Intraductal carcinoma (DCIS) , 1986, Cancer.

[6]  G. Serio,et al.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables. , 1992, Journal of clinical pathology.

[7]  S. Hirohashi,et al.  Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness , 1996, Japanese journal of cancer research : Gann.

[8]  P. Tan,et al.  αB‐crystallin is a useful marker for triple negative and basal breast cancers , 2012, Histopathology.

[9]  B. Fisher,et al.  Scar cancers: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4) — IX , 2005, Breast Cancer Research and Treatment.

[10]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[11]  A. Gown,et al.  Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma , 2004, Clinical Cancer Research.

[12]  C. Perou,et al.  Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma , 2006, Modern Pathology.

[13]  H. Tsuda,et al.  Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Histopathological Prognostic Parameter for Tumor Recurrence and Tumor Death within Three Years after the Initial Operation , 1997, Japanese journal of cancer research : Gann.

[14]  I. Ellis,et al.  Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast , 2010, Modern Pathology.

[15]  H. Tsuda,et al.  New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus , 2000, Pathology international.

[16]  C. Colpaert,et al.  A fibrotic focus is a prognostic factor and a surrogate marker for hypoxia and (lymph)angiogenesis in breast cancer: review of the literature and proposal on the criteria of evaluation , 2007, Histopathology.

[17]  A. Ochiai,et al.  Prognostic Significance of Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Prospective Observational Study , 2002, Modern Pathology.